1
0
42 U.S.C. § 284m–1 — Pediatric Advisory Committee(uscode.house.gov)
submitted 24 years ago by Pub. L. 107-109 to r/title-42-THE-PUBLIC-HEALTH-AND-WELFARE
search results for “42 U.S.C. § 355a”
2
0
21 U.S.C. § 355f — Extension of exclusivity period for new qualified infectious disease products(uscode.house.gov)
submitted 88 years ago by Pub. L. 112-144 to r/title-21-FOOD-AND-DRUGS
3
0
42 U.S.C. § 284m — Program for pediatric studies of drugs(uscode.house.gov)
submitted 82 years ago by Pub. L. 107-109 to r/title-42-THE-PUBLIC-HEALTH-AND-WELFARE
4
0
21 U.S.C. § 355c–1 — Report(uscode.house.gov)
submitted 14 years ago by Pub. L. 112-144 to r/title-21-FOOD-AND-DRUGS
5
0
21 U.S.C. § 353 — Exemptions and consideration for certain drugs, devices, and biological products(uscode.house.gov)
submitted 88 years ago by ch. 675 to r/title-21-FOOD-AND-DRUGS
6
0
42 U.S.C. § 262 — Regulation of biological products(uscode.house.gov)
submitted 82 years ago by ch. 373 to r/title-42-THE-PUBLIC-HEALTH-AND-WELFARE
7
0
21 U.S.C. § 355a — Pediatric studies of drugs(uscode.house.gov)
submitted 88 years ago by Pub. L. 105-115 to r/title-21-FOOD-AND-DRUGS
8
0
21 U.S.C. § 355 — New drugs(uscode.house.gov)
submitted 88 years ago by ch. 675 to r/title-21-FOOD-AND-DRUGS
9
0
42 U.S.C. § 282 — Director of National Institutes of Health(uscode.house.gov)
submitted 82 years ago by Pub. L. 99-158 to r/title-42-THE-PUBLIC-HEALTH-AND-WELFARE